Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma

American Journal of Rhinology

Volumn 12, Issue 2, 1998, Pages 119-124

  Fang, Sheen Yie ^a   Jin Jou, Van ^a   Ohyama, Masuru ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MULTIPLE CANCER; NOSE CAVITY; NOSE TUMOR; PAPILLOMA; PARANASAL SINUS TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL CAVITY; NEOPLASMS, MULTIPLE PRIMARY; NOSE NEOPLASMS; PAPILLOMA; PARANASAL SINUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032020503     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898781390235     Document Type: Article

References (31)

1. Macdonald MR, Le KT, Freeman J, et al. A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer 75:2307-2312, 1995.
2. Bielamowicz S, Calcaterra TC, Watson D. Inverting papilloma of the head and neck: The UCLA update. Otolaryngol Head Neck Surg 109:71-76, 1993.
3. Phillips PP, Gustafson RO, Facer GW. The clinical behavior of inverting papilloma of the nose and paranasal sinuses: Report of 112 cases and review of the literature. Laryngoscope 100:463-469, 1990.
4. Lasser A, Rothfeld PR, Shapiro RS. Epithelial papilloma and squamous cell carcinoma of the nasal cavity and paranasal sinuses: A clinicopathological study. Cancer 38:2503-2510, 1976.
5. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol 166:389-394, 1992.
6. Lane DP. Cancer. p53, guardian of the genome [news, comment] [see comments] Nature 358:15-16, 1992.
7. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:321-326, 1994.
8. Bartek J, Iggo R, Cannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893-899, 1990.
9. Xu L, Chen YT, Huvos AG, et al. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagn Mol Pathol 3:83-92, 1994.
10. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6:1785-1789, 1991.
11. Urakami S, Igawa M, Shirakawa H, et al. Biologic characteristics of inverted papilloma of the urinary bladder. Br J Urol 77:55-60, 1996.
12. Livingstone LR, White A, Sprouse J, et al. Altered cell cycle arrest and gene amplification potential accompany loss of wildtype p53. Cell 70:923-935, 1992.
13. Lowe SW, Bodis S, McClatchey A, et al. P53 status and the efficacy of cancer therapy in vivo. Science 266:807-810, 1994.
14. Field JK, Spandidos DA, Malliri A, et al. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 64:573-577, 1991.
15. Lavertu P, Roberts JK, Kraus DH, et al. Squamous cell carci-noma of the paranasal sinuses: The Cleveland Clinic experience 1977-1986. Laryngoscope 99:1130-1136, 1989.
16. Field JK, Pavelic ZP, Spandidos DA, et al. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 119:1118-1122, 1993.
17. Hyaras VJ. Papillomas of the nasal cavity and paranasal sinuses: A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 80:192-206, 1971.
18. Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 105:178-183, 1995.
19. Banks L, Matlashwski G, Crawford L. Isolation of human-p53specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529-534, 1986.
20. Cagle PT, Brown RW, Lebovitz ML. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. Hum Pathol 25:443-448, 1994.
21. Baas IO, Mulder JW, Offerhaus GJ, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12, 1994.
22. Carder PJ, Cripps KJ, Morris R, et al. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. BrJ Cancer 71:215-218, 1995.
23. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991.
24. Bennett WP, Hollstein MC, Metcalf RA, et al. P53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52:6092-6097, 1992.
25. Furuta Y, Shinohara T, Sano K, et al. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope 101:79-85, 1991.
26. Scheffner M, Werness BA, Huibregtse JM, et al. The e6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136, 1990.
27. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sei U S A 88:5523-5527, 1991.
28. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 e6 proteins with p53. Science 248:76-79, 1990.
29. Matlashewski G, Banks L, Pirn D, Crawford L. Analysis of human p53 proteins and mrna levels in normal and transformed cells. Eur J Biochem 154:665-672, 1986.
30. Gallo O, Chiarelli I, Bianchi S, et al. Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer. Clin Cancer Res 2:1577-1582, 1996.
31. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]. Nature 362:849-852, 1993. D